Annual balance sheet for Genprex, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 38.6 | 21 | 6.74 | 1.6 | 7.83 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0 | 0.035 | 0 | — | — |
| Prepaid Expenses | |||||
| Total Current Assets | 39.1 | 21.5 | 7.53 | 2.08 | 8.36 |
| Net Property, Plant And Equipment | 0.049 | 0.023 | 0.008 | 0 | 0 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 42.9 | 25.1 | 10.7 | 4.12 | 10.2 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.59 | 2.81 | 3.25 | 2.5 | 2.17 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1.59 | 2.81 | 3.25 | 2.5 | 2.2 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 41.3 | 22.3 | 7.42 | 1.62 | 7.96 |
| Total Liabilities & Shareholders' Equity | 42.9 | 25.1 | 10.7 | 4.12 | 10.2 |
| Total Common Shares Outstanding |